CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
13 hedge funds and large institutions have $1.4M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$278K | |
| 2 | +$131K | |
| 3 | +$14.4K | |
| 4 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$4.05K |
Top Sellers
| 1 | -$411K | |
| 2 | -$271K | |
| 3 | -$191K | |
| 4 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$166K |
| 5 |
Focus Partners Wealth
Boston,
Massachusetts
|
-$26K |